Therapeutic Advances in Advanced Basal Cell Carcinoma

By sjmartinez • September 15, 2024

Alkassis S, Shatta M, Wong DJ. Therapeutic Advances in Advanced Basal Cell Carcinoma. Cancers (Basel). 2024 Sep 4;16(17):3075. doi: 10.3390/cancers16173075. PMID: 39272933; PMCID: PMC11394629.

Tags: anti-PD1, basal cell carcinoma, Checkpoint Inhibitor, Fellow, hedgehog inhibitor, Hematology/Oncology, Publications

Olutasidenib demonstrates significant clinical activity in mutated IDH1 acute myeloid leukaemia arising from a prior myeloproliferative neoplasm

De Botton S, Récher C, Cortes J, Curti A, Fenaux P, Peterlin P, Pigneux A, Yee K, Wei A, Mims A, Schiller G, Chao MM,[...]

Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now

Shore N, Nielsen SM, Esplin ED, Antonarakis ES, Barata PC, Beer TM, Beltran H, Bryce A, Cookson MS, Crawford ED, Dorff TB, George DJ, Heath[...]

Retrospective Study of CD20 Expression Loss in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Marshalek JP, Qing X, Dragan M, Tomassetti S. Retrospective Study of CD20 Expression Loss in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma. J Hematol. 2024 Dec;13(6):268-277.[...]